Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer

Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a post by Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals on X, adding:

“Really important discussion about this new guideline.”

Quoting Timothée Olivier’s post:

“Journal of Clinical Oncology updated their recommendation about adjuvant use of CDK4/6 inhibitors in early breast cancer.

Are patients protected enough?

See our analysis below.”

Additional information.
Source: Vinay Prasad/X and Timothée Olivier/X